摘要
目的:探讨DSA脑血管造影对比剂(造影剂)在血管狭窄和血管畸形中的临床应用。方法:回顾性分析本院2014年6月-2016年3月收治的150例血管狭窄和血管畸形患者的临床资料,分为血管狭窄组和血管畸形组,每组75例,两组均行DSA脑血管造影术,比较其诊断准确率以及造影剂的并发症、术后生命体征情况。结果:血管狭窄组诊断准确率为98.67%,血管畸形组为97.33%,两组比较差异无统计学意义(P>0.05)。血管狭窄组出现轻度并发症3例,中度并发症5例,重度并发症3例,并发症发生率为14.67%;血管畸形组分别为1、1、1例,并发症发生率为4.00%,两组比较差异有统计学意义(P<0.05)。术后血管畸形组患者的呼吸、体温、脉搏、血压均优于血管狭窄组,差异均有统计学意义(P<0.05)。结论:DSA脑血管造影术对血管狭窄、血管畸形等有较高准确率,需根据血管病变的情况选择合适的剂量、流速,以降低并发症的发生。
Objective： To explore the DSA cerebrovascular imaging contrast agent （ contrast ） in the clinical application of vascular stenosis and vascular malformation.Method： 150 patients with vascular stenosis and vascular malformation clinical data in our hospital from June 2014 to March 2016 were retrospectively analyzed, they were divided into the vascular stenosis group and vascular malformation group, 75 cases in each group, they were all given DSA in cerebral angiography, the diagnostic accuracy , the complications and postoperative vital signs of the contrast agent of two groups were compared.Result： The diagnostic accuracy of vascular stenosis group was 98.67%, the vascular malformation group was 97.33%, the difference was no statistically significant （ P〉0.05 ） . Vascular stenosis group appeared mild complications in 3 patients, moderate complications in 5 cases, 3 cases of severe complications, the complication rate was 14.67%; vascular malformation group respectively was 1, 1, 1 case, the complication rate was 4.00%, the difference was statistically significant （ P〈0.05 ） .Postoperative vascular malformation patients breathing, body temperature, pulse and blood pressure were better than that of the vascular stenosis group, the differences were statistically significant （P〈0.05） .Conclusion： DSA cerebral angiography in vascular stenosis, vascular malformation, and so on has higher accuracy, need according to the situation to choose the appropriate dose of vascular lesions and the velocity, in order to reduce the occurrence of complications.
作者
黄德堂
HUANG De-tang(The First Affiliated Hospital of Guangxi University, Liuzhou 545002, Chin)
出处
《中国医学创新》
CAS
2017年第6期33-36,共4页
Medical Innovation of China
